Literature DB >> 22700602

Spinocerebellar ataxia type 2 is associated with Parkinsonism and Lewy body pathology.

Masaki Takao1, Masahiro Aoyama, Kinya Ishikawa, Yoshio Sakiyama, Harumi Yomono, Yuko Saito, Hiroshi Kurisaki, Ban Mihara, Shigeo Murayama.   

Abstract

Clinical phenotype of individuals with spinocerebellar ataxia 2 (SCA2) is characterised by cerebellar ataxia and cognitive impairment. Although L-dopa-responsive Parkinsonism is considered as a rare clinical presentation in SCA2, it has been brought to the attention of many neurologists in several studies. The authors report an autopsy case of SCA2 with Parkinsonism from a Japanese family using archival materials of our Brain Bank to describe unique neuropathologic findings. The individual clinically showed Parkinsonism as a predominant phenotype instead of cerebellar ataxia. Besides the classic SCA2 neuropathologic alterations, Lewy bodies and Lewy neurites were present in the brainstem nuclei. Genetic analysis revealed shorter abnormal expansion of CAG repeats (less than 39). In contrast, the authors could not find α-synuclein pathology in two SCA2 cases without Parkinsonism. The present case will provide a neuropathologic evidence of correlation between α-synucleinopathy and Parkinsonism of SCA2 as well as shed light on understanding the pathomechanism of Parkinsonism in SCA2.

Entities:  

Mesh:

Year:  2011        PMID: 22700602      PMCID: PMC3079476          DOI: 10.1136/bcr.01.2011.3685

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  19 in total

Review 1.  Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond.

Authors:  Alexandra Durr
Journal:  Lancet Neurol       Date:  2010-09       Impact factor: 44.182

2.  'Hot-cross bun sign' of multiple system atrophy.

Authors:  Masaki Takao; Taro Kadowaki; Yutaka Tomita; Yoji Yoshida; Ban Mihara
Journal:  Intern Med       Date:  2007-11-16       Impact factor: 1.271

3.  Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies.

Authors:  R Estrada; J Galarraga; G Orozco; A Nodarse; G Auburger
Journal:  Acta Neuropathol       Date:  1999-03       Impact factor: 17.088

4.  Parkinson's disease: a broken nosology.

Authors:  John Hardy; Andrew J Lees
Journal:  Mov Disord       Date:  2005-08       Impact factor: 10.338

5.  [Autopsy case of SCA2 with Parkinsonian phenotype].

Authors:  Harumi S Yomono; Hiroshi Kurisaki; Akira Hebisawa; Yoshio Sakiyama; Yuko Saito; Shigeo Murayama
Journal:  Rinsho Shinkeigaku       Date:  2010-03

6.  Dominantly inherited olivopontocerebellar atrophy from eastern Cuba. Clinical, neuropathological, and biochemical findings.

Authors:  G Orozco; R Estrada; T L Perry; J Araña; R Fernandez; A Gonzalez-Quevedo; J Galarraga; S Hansen
Journal:  J Neurol Sci       Date:  1989-10       Impact factor: 3.181

7.  Incidental Lewy body disease and preclinical Parkinson disease.

Authors:  Anthony DelleDonne; Kevin J Klos; Hiroshige Fujishiro; Zeshan Ahmed; Joseph E Parisi; Keith A Josephs; Roberta Frigerio; Melinda Burnett; Zbigniew K Wszolek; Ryan J Uitti; J Eric Ahlskog; Dennis W Dickson
Journal:  Arch Neurol       Date:  2008-08

Review 8.  Spinocerebellar ataxia 2 (SCA2).

Authors:  Isabel Lastres-Becker; Udo Rüb; Georg Auburger
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

9.  Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies). Clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families.

Authors:  A Dürr; D Smadja; G Cancel; A Lezin; G Stevanin; J Mikol; R Bellance; G G Buisson; H Chneiweiss; J Dellanave
Journal:  Brain       Date:  1995-12       Impact factor: 13.501

10.  Phenotype variation correlates with CAG repeat length in SCA2--a study of 28 Japanese patients.

Authors:  H Sasaki; A Wakisaka; K Sanpei; H Takano; S Igarashi; T Ikeuchi; K Iwabuchi; T Fukazawa; T Hamada; T Yuasa; S Tsuji; K Tashiro
Journal:  J Neurol Sci       Date:  1998-08-14       Impact factor: 3.181

View more
  11 in total

Review 1.  Diagnosis and differential diagnosis of MSA: boundary issues.

Authors:  Han-Joon Kim; Beom S Jeon; Kurt A Jellinger
Journal:  J Neurol       Date:  2015-02-07       Impact factor: 4.849

Review 2.  Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature.

Authors:  Susanne A Schneider; Roy N Alcalay
Journal:  Mov Disord       Date:  2017-11       Impact factor: 10.338

3.  Reduced cardiac 123I-metaiodobenzylguanidine uptake in patients with spinocerebellar ataxia type 2: a comparative study with Parkinson's disease.

Authors:  Anna De Rosa; Sabina Pappatà; Teresa Pellegrino; Maria Fulvia De Leva; Gennaro Maddaluno; Giovanni Fiumara; Raffaella Carotenuto; Mario Petretta; Alessandro Filla; Giuseppe De Michele; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-09       Impact factor: 9.236

Review 4.  Parkinsonism in spinocerebellar ataxia.

Authors:  Hyeyoung Park; Han-Joon Kim; Beom S Jeon
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

5.  Autopsy case of the C12orf65 mutation in a patient with signs of mitochondrial dysfunction.

Authors:  Hideaki Nishihara; Masatoshi Omoto; Masaki Takao; Yujiro Higuchi; Michiaki Koga; Motoharu Kawai; Hiroo Kawano; Eiji Ikeda; Hiroshi Takashima; Takashi Kanda
Journal:  Neurol Genet       Date:  2017-07-27

6.  Interrupted CAG expansions in ATXN2 gene expand the genetic spectrum of frontotemporal dementias.

Authors:  Clémence Fournier; Vincent Anquetil; Agnès Camuzat; Sandrine Stirati-Buron; Véronique Sazdovitch; Laura Molina-Porcel; Sabrina Turbant; Daisy Rinaldi; Raquel Sánchez-Valle; Mathieu Barbier; Morwena Latouche; Giovanni Stevanin; Danielle Seilhean; Alexis Brice; Charles Duyckaerts; Isabelle Le Ber
Journal:  Acta Neuropathol Commun       Date:  2018-05-30       Impact factor: 7.801

Review 7.  Spinocerebellar Ataxia Type 2: Clinicogenetic Aspects, Mechanistic Insights, and Management Approaches.

Authors:  Luis C Velázquez-Pérez; Roberto Rodríguez-Labrada; Juan Fernandez-Ruiz
Journal:  Front Neurol       Date:  2017-09-11       Impact factor: 4.003

Review 8.  Lewy body disease or diseases with Lewy bodies?

Authors:  Kateřina Menšíková; Radoslav Matěj; Carlo Colosimo; Raymond Rosales; Lucie Tučková; Jiří Ehrmann; Dominik Hraboš; Kristýna Kolaříková; Radek Vodička; Radek Vrtěl; Martin Procházka; Martin Nevrlý; Michaela Kaiserová; Sandra Kurčová; Pavel Otruba; Petr Kaňovský
Journal:  NPJ Parkinsons Dis       Date:  2022-01-10

9.  Parkinson's disease associated with pure ATXN10 repeat expansion.

Authors:  Birgitt Schüle; Karen N McFarland; Kelsey Lee; Yu-Chih Tsai; Khanh-Dung Nguyen; Chao Sun; Mei Liu; Christie Byrne; Ramesh Gopi; Neng Huang; J William Langston; Tyson Clark; Francisco Javier Jiménez Gil; Tetsudo Ashizawa
Journal:  NPJ Parkinsons Dis       Date:  2017-09-05

10.  The Respiratory Phenotype of Rodent Models of Amyotrophic Lateral Sclerosis and Spinocerebellar Ataxia.

Authors:  Anna F Fusco; Angela L McCall; Justin S Dhindsa; Logan A Pucci; Laura M Strickland; Amanda F Kahn; Mai K ElMallah
Journal:  J Neuroinflamm Neurodegener Dis       Date:  2019-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.